Lv33
270 积分 2023-05-20 加入
A randomized, double-blinded, phase III study of icaritin versus huachashu as the first-line therapy in biomarker-enriched HBV-related advanced hepatocellular carcinoma with poor conditions: Interim analysis result
11天前
已完结
基层医疗机构失眠症诊断和治疗中国专家共识
1个月前
已完结
皖公网安备34019202002308
